These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24013821)

  • 21. EBV-specific T-cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease.
    Wilsdorf N; Eiz-Vesper B; Henke-Gendo C; Diestelhorst J; Oschlies I; Hussein K; Pape L; Baumann U; Tönshoff B; Pohl M; Höcker B; Wingen AM; Klapper W; Kreipe H; Schulz TF; Klein C; Maecker-Kolhoff B
    Transplantation; 2013 Jan; 95(1):247-55. PubMed ID: 23222899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T; Zwick DL; Rothberg PG; Warady BA
    Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
    Chan TS; Hwang YY; Gill H; Au WY; Leung AY; Tse E; Chim CS; Loong F; Kwong YL
    Clin Transplant; 2012; 26(5):679-83. PubMed ID: 22324300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas.
    Swinnen LJ
    Semin Oncol; 2000 Aug; 27(4):402-8. PubMed ID: 10950366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.
    Orjuela MA; Alobeid B; Liu X; Siebert AL; Kott ER; Addonizio LJ; Morris E; Garvin JH; Lobritto SJ; Cairo MS
    Br J Haematol; 2011 Mar; 152(6):733-42. PubMed ID: 21275950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA; Jauregui MP; Hsi ED; Novoa-Takara L; Chang CC
    Hum Pathol; 2006 Sep; 37(9):1130-6. PubMed ID: 16938517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ
    Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of early and late PTLD development in pediatric solid organ transplant recipients.
    Schober T; Framke T; Kreipe H; Schulz TF; Großhennig A; Hussein K; Baumann U; Pape L; Schubert S; Wingen AM; Jack T; Koch A; Klein C; Maecker-Kolhoff B
    Transplantation; 2013 Jan; 95(1):240-6. PubMed ID: 23222898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
    Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
    Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
    Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having posttransplant lymphoproliferative disorders.
    Cho YU; Chi HS; Jang S; Park SH; Park CJ
    Am J Clin Pathol; 2014 Feb; 141(2):268-74. PubMed ID: 24436276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
    Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I
    Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014.
    Seçkin D
    G Ital Dermatol Venereol; 2014 Aug; 149(4):401-8. PubMed ID: 25068227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment.
    Overkamp M; Granai M; Bonzheim I; Steinhilber J; Schittenhelm J; Bethge W; Quintanilla-Martinez L; Fend F; Federmann B
    Virchows Arch; 2021 Jun; 478(6):1135-1148. PubMed ID: 33324999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How I treat posttransplant lymphoproliferative disorder.
    Amengual JE; Pro B
    Blood; 2023 Oct; 142(17):1426-1437. PubMed ID: 37540819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.
    Karuturi M; Shah N; Frank D; Fasan O; Reshef R; Ahya VN; Bromberg M; Faust T; Goral S; Schuster SJ; Stadtmauer EA; Tsai DE
    Transpl Int; 2013 Jun; 26(6):616-22. PubMed ID: 23551167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posttransplant lymphoproliferative disorder of the central nervous system.
    Kempf C; Tinguely M; Rushing EJ
    Pathobiology; 2013; 80(6):310-8. PubMed ID: 24013167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.
    Loomis R; Carbone R; Reiss M; Lacy J
    Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.